3.0.0 6173 2023-01-11T13:21:35Z 2023-01-11T13:21:35Z House H HR 2010-09-22 111 hsif00 Energy and Commerce Committee House Standing Referred to 2010-09-22T18:01:17Z 2010-09-22 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2010-09-22 Introduced in House IntroReferral Intro-H 9 Library of Congress 2010-09-22 Introduced in House IntroReferral 1000 9 Library of Congress C000243 Rep. Castle, Michael N. [R-DE-At Large] MICHAEL CASTLE R DE N. N D000197 Rep. DeGette, Diana [D-CO-1] DIANA DEGETTE D CO 1 2010-09-22 True Health Advisory bodies Department of Health and Human Services Drug safety, medical device, and laboratory regulation Executive agency funding and structure Genetics Health programs administration and funding Health technology, devices, supplies Medical research Product development and innovation Research administration and funding Research and development Health 00 2010-09-22 Introduced in House 2010-12-03T22:43:19Z Regenerative Medicine Promotion Act of 2010 - Requires the Secretary of Health and Human Services (HHS) to: (1) submit to Congress a report identifying all ongoing federal programs and activities regarding regenerative medicine; and (2) establish a Regenerative Medicine Coordinating Council in the Office of the Secretary. Includes among the duties of the Council: (1) preparing a national strategy for the promotion of research into regenerative medicine and the development of drugs, biological products, medical devices, and biomaterials for use in regenerative medicine; (2) identifying sources of funding for research into regenerative medicine and areas where such funding is inadequate; and (3) making recommendations regarding federal policies to support development and marketing of regenerative medicine products.

Authorizes the Secretary, acting through the Director of the National Institutes of Health (NIH), to make grants for: (1) basic or preclinical research into regenerative medicine; (2) research and development of drugs, biological products, medical devices, and biomaterials for use in regenerative medicine; and (3) the making of an investigational new drug application or an investigational device exemption application within four years of receiving such grant.

Amends the Public Health Service Act to authorize the Director of NIH to award grants, contracts, or cooperative agreements to accelerate the development of high need cures through the development of medical products and behavioral therapies for use in regenerative medicine.

Authorizes the Secretary, acting through the Commissioner of Food and Drugs, to: (1) conduct, support, or collaborate in regulatory research to assist the Food and Drug Administration (FDA) in performing its functions with respect to regenerative medicine; or (2) make grants to fund regulatory research for such purpose.

]]> Regenerative Medicine Promotion Act of 2010 Display Title Regenerative Medicine Promotion Act of 2010 Official Title as Introduced To provide for a Federal initiative to support regenerative medicine through increased funding for research and commercial development of regenerative medicine products and development of a regulatory environment that enables rapid approval of safe and effective products, and for other purposes. Introduced in House IH Short Titles as Introduced Regenerative Medicine Promotion Act of 2010 Introduced in House 2010-09-22T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-111hr6173ih/xml/BILLS-111hr6173ih.xml 2010-09-22 Referred to the House Committee on Energy and Commerce. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.